From target to tailored therapy: In the last decade, the intrinsic and acquired resistance of metastatic colon cancer to chemotherapy, on one hand, and the evolution of target identification through translational medicine, on the other, are paving the road to patient-tailored therapy for metastatic CRC, aiming to cure patients basing on the complex interactions among patient’s characteristics, dis?ease physiopathology and drugs’ metabolism.